Sort   by:  
 Page size 
UnknownT-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab.
Not available
S-EPMC6075965 | biostudies-literature
TranscriptomicsStudy for evaluating the effect of cold ischemic time and RNA stabilization method on RNA integrity and gene expression measurements
Time series of eleven breast cancer samples subjected to different cold ischemic stress of up to 3 hr post tumor excision. A different 2x2 factorial within this study evaluated the effect of stabilization method (RNAlater vs snap freezing) and stablization delay (0 and 40 min) at room temperature. T...
ORGANISM(S): Homo sapiens 
2011-11-02 | E-GEOD-25011 | biostudies-arrayexpress
TranscriptomicsGenomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
This SuperSeries is composed of the following subset Series: GSE25055: Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer GSE25065: Validation cohort for genomic predictor of response and survival following neoadju...
ORGANISM(S): Homo sapiens 
2011-05-11 | E-GEOD-25066 | biostudies-arrayexpress
TranscriptomicsFactorial study for evaluating the effect of Affy platform and lab on gene expression measurements
Comparison of concordance in single and multi-gene genomic indices from data generated by two different laboratories (MD Anderson Cancer Center (MDA) and Jules Bordet Institute (JBI)) and on two different Affymetrix platforms (U113A and U133_Plus2). We used a 2x2 factorial study in which 16 clinica...
ORGANISM(S): Homo sapiens 
2010-08-13 | E-GEOD-17700 | biostudies-arrayexpress
TranscriptomicsEndocrine Sensitivity Index Validation Dataset
Validation dataset of 298 ER-positive patients treated with tamoxifen for 5 years. All patients in this dataset have ER+ breast cancer and were uniformly treated with tamoxifen for 5 years. The objective of the study was to correlate levels of genomic markers to outcomes (relapse free survival) in ...
ORGANISM(S): Homo sapiens 
2010-08-13 | E-GEOD-17705 | biostudies-arrayexpress
TranscriptomicsDiscovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
PURPOSE: To develop a predictive test for response and survival following neoadjuvant taxane-anthracycline chemotherapy for HER2-negative invasive breast cancer. METHODS: We developed a microarray-based gene expression test from pre-treatment tumor biopsies (310 patients) to predict favorable outcom...
ORGANISM(S): Homo sapiens 
2011-05-11 | E-GEOD-25055 | biostudies-arrayexpress
TranscriptomicsValidation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
PURPOSE: To develop a predictive test for response and survival following neoadjuvant taxane-anthracycline chemotherapy for HER2-negative invasive breast cancer. METHODS: We developed a microarray-based gene expression test from pre-treatment tumor biopsies (310 patients) to predict favorable outcom...
ORGANISM(S): Homo sapiens 
2011-05-11 | E-GEOD-25065 | biostudies-arrayexpress
TranscriptomicsBreast cancer and liver tissue biopsies used to develop and validate an index for liver contamination in metastatic breast cancer
PURPOSE: To develop an index capable of detecting and quantifying the extent of liver RNA contamination in liver biopsies of metastatic breast cancer METHODS: We developed a microarray-based gene expression liver index by comparing the expression levels of genes in liver tissue biopsies and in prima...
ORGANISM(S): Homo sapiens 
2013-01-05 | E-GEOD-33116 | biostudies-arrayexpress
Sort   by:  
 Page size